Queer Eye's Tan France helps unthread obesity bias as part of Zepbound's 'Changing the Thread Collection'
Lilly announces two new Executive Committee members and expansion of leadership roles to prepare for next wave of growth
Lilly's selective amylin agonist, eloralintide, demonstrated meaningful weight loss and favorable tolerability in a Phase 2 study of adults with obesity or overweight
Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide
Lilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance
Lilly announces more than $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the United States
LillyDirect and Walmart Pharmacy launch first retail pick-up option with direct-to-consumer pricing for Zepbound
Lilly partners with NVIDIA to build the industry's most powerful AI supercomputer, supercharging medicine discovery and delivery for patients
Lilly announces roster of Team USA athletes for the Olympic and Paralympic Games Milano Cortina 2026, pledges to translate U.S. Olympic and Paralympic milestones into meaningful community impact
Lilly's Omvoh approved by U.S. FDA as a single-injection maintenance regimen in adults with ulcerative colitis
Lilly's Omvoh demonstrated early and sustained improvement in bowel urgency outcomes for patients with ulcerative colitis
